Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 949-950 |
Número de páginas | 2 |
Publicación | American Journal of Tropical Medicine and Hygiene |
Volumen | 101 |
N.º | 4 |
DOI | |
Estado | Publicada - 2019 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
Acceder al documento
Otros archivos y enlaces
Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
En: American Journal of Tropical Medicine and Hygiene, Vol. 101, N.º 4, 2019, p. 949-950.
Producción científica: Contribución a una revista › Carta › revisión exhaustiva
TY - JOUR
T1 - Authors' response
AU - Finette, Barry A.
AU - McLaughlin, Megan
AU - Scarpino, Samuel V.
AU - Canning, John
AU - Grunauer, Michelle
AU - Teran, Enrique
AU - Bahamonde, Marisol
AU - Quizhpe, Edy
AU - Shah, Rashed
AU - Swedberg, Eric
AU - Asadur Rahman, Kazi
AU - Khondker, Hosenera
AU - Chakma, Ituki
AU - Muhoza, Denis
AU - Seck, Awa
AU - Kabore, Assiatta
AU - Nibitanga, Salvator
AU - Heath, Barry
N1 - Funding Information: Concern was also expressed by Ansermino et al. about “potential personal bias and commercial interest” influencing the technology development and validation. We agree these are important points to consider. THINKMD is a U.S.-based benefit corporation which by definition is required to develop innovative health technology that has societal impact.5 In addition, the legal structure of a U.S.-based benefit corporation does not require its officers to make decisions that maximize profits at the expense of developing validated high-quality technology and promoting impact.5 We agree that, unfortunately, there are historical and current examples of biased and monetary priorities influencing health technology, medical device, and pharmaceutical companies. However, these issues should be limited for U.S. benefit corporations. With respect to our work, it is important to note that significant financial support for the validation studies was provided by funds from the Ministries of Health of Ecuador and Burkina Faso, University of San Francisco-Quito medical school, United Nations Children’s Fund (UNICEF), and Save the Children regional/local programs. The central goal of this THINKMD collaboration, which includes senior academic physicians and scientists, international aid agency physicians, and senior public health professionals from UNICEF and Save the Children, was to produce a high-quality validated product and perform transparent validation studies. We believe Ansermino’s concerns regarding “bias and monetary commercial interests” for this research consortium are misplaced.
PY - 2019
Y1 - 2019
UR - http://www.scopus.com/inward/record.url?scp=85072990594&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.19-0411b
DO - 10.4269/ajtmh.19-0411b
M3 - Carta
C2 - 32519660
AN - SCOPUS:85072990594
SN - 0002-9637
VL - 101
SP - 949
EP - 950
JO - American Journal of Tropical Medicine and Hygiene
JF - American Journal of Tropical Medicine and Hygiene
IS - 4
ER -